NSC |
Compound |
Enrichment |
Correlation |
NSC 674103 |
2-Acetylimidazo[4,5-b]pyridin 4 p-chlorophenyl 3 thiosemicarbazone |
0.0135714101922724 |
0.2029033 |
NSC 677369 |
Null |
0.0135714101922724 |
0.35545477 |
NSC 686554 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- |
0.0135714101922724 |
0.2696656 |
NSC 688228 |
Null |
0.0135714101922724 |
0.23421183 |
NSC 693248 |
Null |
0.0135714101922724 |
0.11872146 |
NSC 717468 |
Null |
0.0135714101922724 |
0.32978222 |
NSC 718781 |
Erlotinib hydrochloride |
0.0135714101922724 |
-0.30378045 |
NSC 753456 |
2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole |
0.0135714101922724 |
0.29316709 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0139796580235792 |
0.32368294 |
NSC 126228 |
Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0139796580235792 |
0.71566024 |